Drug Type ASO |
Synonyms- |
Target |
Action inhibitors |
Mechanism MUC5B inhibitors(mucin 5B, oligomeric mucus/gel-forming inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Preclinical | United States | 25 Sep 2025 |





